BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28
• 31

• Press Releases

  vTv Therapeutics Announces 2024 Fourth Quarter and Full Year Financial Results and Provides Corporate Update

  March 20, 2025

   · 

  11 min read
• Press Releases

  Erasca Reports Fourth Quarter and Full Year 2024 Business Updates and Financial Results

  March 20, 2025

   · 

  14 min read
• Press Releases

  Skye Bioscience Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

  March 20, 2025

   · 

  14 min read
• Press Releases

  Tenon Medical Reports Fourth Quarter and Full Year 2024 Financial Results

  March 20, 2025

   · 

  12 min read
• Press Releases

  Arcellx Appoints Andrew Galligan and Kristin Myers to Its Board of Directors

  March 20, 2025

   · 

  5 min read
• Press Releases

  U.S. FDA approves TREMFYA® (guselkumab), the first and only IL-23 inhibitor offering both subcutaneous and intravenous induction options, for adult patients with moderately to severely active Crohn’s disease

  March 20, 2025

   · 

  24 min read
• Press Releases

  Nektar Therapeutics to Participate in the H.C. Wainwright 3rd Annual Autoimmune & Inflammatory Disease Virtual Conference

  March 20, 2025

   · 

  1 min read
• Press Releases

  Novartis receives third FDA approval for oral Fabhalta® (iptacopan) - the first and only treatment approved in C3 glomerulopathy (C3G)

  March 20, 2025

   · 

  16 min read
• Press Releases

  Pint Pharma Announces ANVISA’s Approval of BESREMi® (ropeginterferon alfa-2b) for the Treatment of Polycythemia Vera

  March 20, 2025

   · 

  4 min read